Antibodies to anthrax protective antigen can neutralize as well as enhance the anthrax lethal toxin action
被引:0
|
作者:
Shemyakin, I
论文数: 0引用数: 0
h-index: 0
机构:
State Res Ctr Appl Microbiol, Obolensk, Moscow, RussiaState Res Ctr Appl Microbiol, Obolensk, Moscow, Russia
Shemyakin, I
[1
]
Dubiley, S
论文数: 0引用数: 0
h-index: 0
机构:State Res Ctr Appl Microbiol, Obolensk, Moscow, Russia
Dubiley, S
机构:
[1] State Res Ctr Appl Microbiol, Obolensk, Moscow, Russia
[2] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
来源:
Multidisciplinarity for Parasites, Vectors and Parasitic Diseases, Vol 1
|
2004年
关键词:
D O I:
暂无
中图分类号:
R38 [医学寄生虫学];
Q [生物科学];
学科分类号:
07 ;
0710 ;
09 ;
100103 ;
摘要:
Next generation of anti-anthrax vaccine must be based on well-defined component(s) eliciting easily assessed protective immune response. It is widely accepted that the anthrax protective antigen (PA) would be the key component of such a vaccine. At the same time, recent studies indicate that the immune response to the PA is complex, and additional research is needed to prepare safe and efficient PA-based vaccine prototype. In the present communication we discuss recently reported phenomenon of the antibody mediated enhancement of lethal toxin action.